14、Othsu A，Baba H，SakataY,et al.Phase II study of s-l,a novel oral fluoropyfin idine derivative in patients with metastatic colorectal cancer.Br J Cancer，2000，83:141-145.

15、Miwa M，Ura M， Nish idaM，et al.Design of a norel oral fluoropyrinidine carbamate，capecitabine， which generatess 5- fluorouracil selectively in tumours by enzymes concentra        ted in human liver and cancer tissue. Eur J Cancer，1998，34:1274一1281.

16、M iyadera K，Sum izawa T，Haraguchi M，et al.Role of thymidine phosphory lase          aetivity in the angiogenic effeet of platelet derived endothelial cell growth   faetor/thym idine phosphorylase.Cancer Res，1995，55:1687-1690.

17、Mettem J，Koommagi R,Volm M.Bionlogical charaeterization of subgroups of      squamous cell lung carcinomas.Clin Caneer Res，1999，5:1459.

18、Koizumi W，Salgenji K，Nakamaru N，et al.Prediction of response to 5-deoxy-5-fiuorouridine(5- DFUR)in patiens with inoperable advance.gastric cancer by immunostaining of thylnidine phosphorylase/plateletderived endothelial cell growth factor.Oncology， 1999，56:215.

19、 Cutsem EV，Findlay M，Osterwalder B，et al.Capecitabine，  an oral fluoropyrimidine

Carbamate with substantial activity in advanced colorectal cancer:Results of a     randomized phase II study.J Clin Oncol，2000，18:1337~1345.

20、 Hoff PM，Ansari R，Batist G，et al.Comparison of oral capecitabine versus  intravenous fluorouracil plus leucovorin as first- line treatment in 605 patients with metastatic coloreetal cancer:Reusults of a randomized Phase III study.J Clin Oncol，2001，19:2282-2292.

21、张军，王严庆，吴凯南.甲酰四氢叶酸钙对5-Fu的增效作用及在结直肠癌化疗中的应用，国外医学外科学分册，1996，23:340-344.

22、刘新春，程玉峰，李得爱.实用抗肿瘤药物治疗学.北京:人民卫生出版社，2001.636.

23、林万隆.奥沙利铂的药理作用及临床应用，中国肿瘤临床，2000，27:872-874.

24、Bleierg H.Oxaliplatin(L-OHP):a new reality in colorectal cancer. Br J Cancer，1998，77:l-3.

25、BecouarnY， Rougier P.Clinical efficacy of oxaliplatin monotherapy:phase    trials

 in advanced colorectal cancer， Semin oncol，1998，25:23-31.

26、 Jin ML，Chen Q， Cheng FQ，et al.Oxaliplatin(OXA) in combination with LV/5-       FU2 inChinese patients with advanced gastric cancer(AGC).Proc ASCO,2002，21:558-560.

27、Raymond E，Faivre S， Woynarow ski JM，et al.Oxaliplatin in echanism of  action and antineoplastic activity.Semin oncol，1998，25:4-12.

28、刘基巍，班丽英，高亚杰，等.国产奥沙利铂治疗结直肠癌II期临床研究.临床肿瘤杂志，2000，5:178-180.

29、金憋林，陈强，程凤歧，等.奥沙利铂联合亚叶酸钙和5-氟尿嘧啶治疗晚期胃癌的研究.中华肿瘤杂志，2003， 25:172- 174.

30、Louvet C，De gramant A.Role and value of oxaliplatin in metastatic   colorectal cancers.Rev Med Inteme，1997，18:368一371.

31、孙燕，管忠震，金懋林，等.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期结直肠癌II期临床试用报告.癌症，1999，18:237-240.

32、Weh HJ， Wilke HJ，Dierlamm J，et al.Weekly therapy with folinic acid(FA)  and high-dose 5-fluorouracil(5- Fu)24- hour infusion in pretreated patients with metastatic colorectal carcinoma.A multicenter study by the Association of Medical Oncology of the German Cancer Soeiety(AIO). Ann Oncol，1994，5:233-237.

33、Andre T，ColinP，Louvet C，et al.Semimonthly versus monthly regimen of          fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer:results of a randomized trial.J Clin Oncol，2003，21:2896-2903.

34、Lokich JJ， Ahlgren JD，Gullo JJ，etal. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma:a Mid- Atlantic Oncology program study.J Clin Oncol， 19897:425-432.

35、Kohne CH，Wils J，Lorenz M，et al.Randomized phase IIIstudy of high-dose     fluorouracil given as a weekly 24- hour infusion with or without leucovorin  versus bolus fluorouracil plus leucovorin in advanced colorectal cancer:European organization of Rese